Auwaerter Paul Gisbert bought CAPR
January 5, 2026 · Form 4 insider transaction
Auwaerter Paul Gisbert bought 1,360 shares of Capricor Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
1,360
Price
$0.00
Total value
N/A
InsiderAuwaerter Paul Gisbert
RoleDirector
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateJanuary 5, 2026
Filing dateJanuary 7, 2026
Shares owned after1,360
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The shares of the award are fully vested and exercisable as of January 5, 2026, the date of the grant. The award pertains to annual board committee service.